Offstream
news

---

Changes

1. Kazakhstan suspends talks with AstraZeneca for purchasing its vaccine amid a reports of severe-side effects in many countries.
   2021-03-17 15:06:26 (First version)
2. Kazakhstan suspends talks with AstraZeneca for purchasing its vaccine amid a claims of severe-side effects in many countries although no causal link has been proven.
   2021-03-17 17:06:24 (Update)
3. Kazakhstan suspends talks with AstraZeneca for purchasing its vaccine amidst claims of severe side-effects in many countries.
   2021-03-18 03:06:03 (Update)
4. Kazakhstan suspends talks with AstraZeneca for purchasing its vaccine amidst reports of severe side effects in many countries.
   2021-03-18 17:06:27 (Update)
5. Kazakhstan suspends talks with AstraZeneca for purchasing its vaccine amidst fears of blood clots in many countries.
   (Current version)

---

Related

Taoiseach Micheál Martin receives his first dose of the AstraZeneca vaccine.
2021-05-9

Yemen begins their COVID-19 vaccination campaign using the vaccine produced by AstraZeneca and the University of Oxford.
2021-04-20

Toronto Mayor John Tory receives his first dose of the AstraZeneca vaccine.
2021-04-10

Clinical trials for the vaccine produced by Oxford and AstraZeneca show that it is 79% effective against COVID-19.
2021-03-22

Italy invokes the European Union powers to block shipment of 250,700 doses of the Oxford–AstraZeneca vaccine to Australia amid escalations between the bloc and AstraZeneca. The European Commission endorses the move.
2021-03-4

AstraZeneca-Oxford developers say that their vaccine candidate is effective against the UK variant of SARS-CoV-2.
2021-02-5

Kyrgyzstan is expected to receive 504,000 doses of the Oxford-AstraZeneca vaccine in March.
2021-02-2

Chile's health regulator approves a vaccine developed by the University of Oxford and AstraZeneca for emergency use in the country.
2021-01-27

Brazil begins distribution of the AstraZeneca-Oxford University vaccine.
2021-01-23

India approves the emergency use of the vaccine developed by the University of Oxford and AstraZeneca, becoming the third country in the world to do so after the United Kingdom and Argentina.
2021-01-1